Ilaria Del Giudice


Titolo Pubblicato in Anno
Sialylation regulates migration in chronic lymphocytic leukemia HAEMATOLOGICA 2023
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature. BRITISH JOURNAL OF HAEMATOLOGY 2023
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi HEMASPHERE 2023
Achieving the Cure of Follicular Lymphoma: is it Time to Finalize Treatment Strategies to Reach This Goal in a Subset of Patients? MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES 2023
Additional lesions identified by genomic microarrays are associated with an inferior outcome in low-risk chronic lymphocytic leukaemia patients BRITISH JOURNAL OF HAEMATOLOGY 2023
Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet {PCR} improve measurable residual disease monitoring in chronic lymphoid malignancies? FRONTIERS IN ONCOLOGY 2023
Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES 2023
Early clearance of hairy cell leukaemia in the bone marrow after first‐line treatment with cladribine predicts a favourable outcome BRITISH JOURNAL OF HAEMATOLOGY 2023
XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling BRITISH JOURNAL OF HAEMATOLOGY 2023
Long‐term benefit of IGHV mutated patients in a real‐life multicenter cohort of FCR‐treated chronic lymphocytic leukemia HEMATOLOGICAL ONCOLOGY 2023
Measurable residual disease in chronic lymphocytic leukemia. Where do we stand? LEUKEMIA 2023
Treatment with ibrutinib does not induce a TP53 clonal evolution in chronic lymphocytic leukemia HAEMATOLOGICA 2022
Blast morphology in the diagnostic work-up of Ph-like acute lymphoblastic leukemia LEUKEMIA & LYMPHOMA 2022
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study CANCERS 2022
Circulating cell‐free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre‐analytical biases HEMATOLOGICAL ONCOLOGY 2022
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study HEMATOLOGICAL ONCOLOGY 2022
Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study BLOOD 2022
Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall BRITISH JOURNAL OF HAEMATOLOGY 2022
Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab HAEMATOLOGICA 2021

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma